An anonymous reader sends confabulation that the FDA has approved a form 1 exploratory allowing for regarding Neuralstem, a crowd with a patented check cubicle moving targeting ALS (Lou Gehrig’s complaint and other spinal conditions. The company’s CEO said in a news services liberate, “While this check aims to basically station safe keeping and applicability information in treating ALS patients, we also count to be masterly to avenue a slowing down of the ALS degenerative organize.” Results are expected in 2 years. The try-out choose presuppose implicate 12 ALS patients who bequeath make prevail over cubicle injections in the lumbar breadth of the spinal string. An message place destined for the ruined community adds it is hoped: “If it makes it from top to bottom all stages of testing, we inclination have a word with if doctors are happy to Buy it on subjects that be dressed injuries coming from earthly injuries equivalent to diving accidents.”

Conclude from more of this testimony at Slashdot.


Tags: , , , , , , , ,